Dr. Brendan is a leading researcher in bacterial pathogenesis and vaccine development. He heads both basic and applied research groups, focusing on glycostructures in bacterial diseases and the development of glycoconjugate vaccines through innovative Bioconjugation technology, now advancing through multiple clinical trials. A pioneer in genome sequencing, he co-led major projects on Campylobacter jejuni, Yersinia pestis, Y. enterocolitica, Francisella tularensis, and Clostridium difficile. His work integrates genomic insights to understand bacterial mechanisms and host interactions. Dr. Brendan earned his PhD in Physical Chemistry from the University of Leicester and has held key leadership roles at the London School of Hygiene & Tropical Medicine (LSHTM), where he currently serves as Co-director of the Vaccine Centre.

Dr. Joseph Mwaka is a medical doctor and clinical research professional with extensive experience managing and coordinating health research projects across Africa. He holds an MSc in International Health and Tropical Medicine from the University of Oxford, an MSc in Vaccinology from the University of Siena, and an MPH from Cavendish University Uganda. At Mildmay Research Centre Uganda, he leads multi-institutional research initiatives focused on vaccines, clinical trials, and digital health innovation. His work bridges implementation science, ethics oversight, and public health policy to strengthen immunization systems in low-resource settings. Dr. Mwaka has presented at global scientific forums and co-authored peer-reviewed publications on vaccination strategies, AI in health, and ethical research governance.

Prof. Tingzhong Yang is a Professor and Director at the Research Center for Digital Health Theory and Management, ZJU National Health Big Data Institute. He has advised the WHO on tobacco control and contributed to the WHO Global Action Plan for NCDs prevention. Dr. Yang is also an external faculty member at West Virginia University’s Injury Control Research Center and was invited as an academician of the Russian Academy of Social and Fundamental Sciences. His research focuses on social and behavioral science in health. He has published over 130 international papers and several books, including Health Research: Social and Behavioral Theory and Methods. Dr. Yang developed China-specific models and a theoretical framework for digital health behavior. He is an editor for the Global Journal of Social Sciences Studies.

Huang Wei Ling, born in Taiwan, raised and graduated in medicine in Brazil, specialist in infectious and parasitic diseases, a General Practitioner, Parenteral and Enteral Medical Nutrition Therapist, Acupuncture, Pain Management and Homeopathy. Since 1997, she works with the approach and treatment of all chronic diseases in a holistic way, with treatment guided through the teachings of Traditional Chinese Medicine and Hippocrates. Author of the theory Constitutional Homeopathy of the Five Elements Based on Traditional Chinese Medicine. Author of more than 300 publications about treatment of variety of diseases rebalancing the internal energy.

Dr. Wenxiao Liu specializes in the pathogenesis and control strategies of infectious diseases in dairy cattle. Her research integrates molecular biology and digital technologies to develop rapid diagnostic reagents for common bovine infectious diseases. Dr. Wenxiao Liu is actively involved in the development of novel vaccines against herpesviruses and Brucella, and conducts in-depth studies on the antimicrobial resistance mechanisms of Pasteurella multocida. This includes uncovering the molecular basis of cross-species transmission of antimicrobial-resistant pathogens and resistance genes from livestock and poultry.

Shokoh Parham is currently a researcher at the Universiti Teknologi Malaysia (UTM). Her main field in undergraduate and graduate studies was in chemistry and organic chemistry. She obtained his PhD in material-chemistry at the Universiti Teknologi Malaysia (UTM) in 2016. After that, she joined as a postdoctoral researcher at the Universiti Teknologi Malaysia (UTM) in 2016. She is specialized in advanced materials. Her research interests are biomaterials, nanomaterials, polymers and medical composites.

Dr. Payam Tamizi is a Mechanical Engineer and Business Leader with over a decade of international experience at the intersection of technology, healthcare, and business innovation. He holds an MBA from the University of Würzburg (Germany) and a Doctorate in Business Administration from the University of Côte d’Azur (France). His current work focuses on Advanced Therapy Medicinal Products (ATMPs), including cell and gene-based therapies and regenerative medicine. Dr. Tamizi has completed professional courses in Stem Cell Medicine at Harvard Medical School (2025) and in Essential and Professional Cell Culture Techniques at the Royan Institute. His career is distinguished by a commitment to translating scientific discovery into investment-ready innovation, fostering growth in high-impact healthcare technologies through strategic leadership, interdisciplinary collaboration, and a global perspective.

Dr. Brendan is a leading researcher in bacterial pathogenesis and vaccine development. He heads both basic and applied research groups, focusing on glycostructures in bacterial diseases and the development of glycoconjugate vaccines through innovative Bioconjugation technology, now advancing through multiple clinical trials. A pioneer in genome sequencing, he co-led major projects on Campylobacter jejuni, Yersinia pestis, Y. enterocolitica, Francisella tularensis, and Clostridium difficile. His work integrates genomic insights to understand bacterial mechanisms and host interactions. Dr. Brendan earned his PhD in Physical Chemistry from the University of Leicester and has held key leadership roles at the London School of Hygiene & Tropical Medicine (LSHTM), where he currently serves as Co-director of the Vaccine Centre.

Dr. Chikh is Senior Director of Vaccine Development at Acuitas Therapeutics, where she leads the development of mRNA vaccines and optimization of lipid nanoparticle (LNP) delivery systems. She earned her PhD studying LNP-based cancer vaccines and has extensive experience in vaccine immunology and non-viral gene delivery. Previously, at Vasomune Therapeutics, enGeneand Pfizer, she contributed to the advancement of multiple vaccine and gene therapy programs—across infectious disease, oncology, and immune-mediated indications—that progressed from preclinical research into clinical trials. Her work focuses on translating mechanistic insight and delivery innovation into clinically effective vaccines.

Prior to founding Rational Vaccines, Mr. Fernandez served as the managing director of Mega films, the production arm of Spanish Broadcasting System (SBSA), and CEO of Duende Media, Inc. where he structured over US $100M of film and television financing. Mr. Fernandez is a 9-time EMMY award winning writer/director/producer and the executive producer of the 2014 academy award winning documentary “The Lady In Number Six”.

Dr. Cynthia N. Brysch, PhD is a world-renowned life-science executive recognized for advancing immunology, novel product development, and paradigm-shifting approaches that deliver life-saving medicines and devices from concept through commercialization. With over 20 years of experience spanning both start-up and established global organizations, she is a published biotechnologist, ICH author with international voting rights, and developer of compendial methods adopted worldwide—widely known for elevating the science-to-compliance ratio. She has stewarded 500+ product campaigns, supported 200+ global inspections, and led PAIs and Form 483 remediation's. As Vice President & COO of Devine Guidance International, Inc., she bridges science, regulation and policy to accelerate equitable global access.

Dr. Eduardo Garcia-Toledano is currently working as a Vice President and General Counsel of Global Health, Madrid, Spain. He is heading up the group responsible for the foundation's external liaison with all stakeholders working to support the availability of treatments for childhood cancer and rare diseases on behalf of the company. He has worked on programs for the Spanish Government Ministry of Health, social services and equality. His career has been focused on patient care and case management for patients with chronic and rare diseases, working with laboratories and orphan drugs helping people who need help and are suffering from rare and chronic diseases.

Anne Marie Moulin is an Emeritus Professor at the French National Centre for Scientific Research (CNRS), affiliated with the UMR SPHERE unit in Paris. She is a philosopher, physician, and historian of science with an extensive academic career in France and abroad. Her research focuses on the history of medicine and science, as well as their intersections with culture, particularly in the Arab world and the Mediterranean region. Throughout her career, she has served in various notable roles, including Director of Research at the Centre for Demographic, Economic, and Judicial Studies (CEDEJ) in Egypt and as a member of the board of the French National Agency for Research on AIDS (ANRS).

Dr. Reynolds has a doctorate in psychoanalysis and neuroscience, and he is a Certified Psychoanalyst. He began working with brain injuries in 2016, and from this work he wrote "The Complex Architecture and Healing of Traumatic Brain Injuries (Cambridge Scholars Publishing 2023), and numerous medical journal articles. Also from this work he developed a Clinical Research Project: "Listening to the Brain/Recovering the Brain/Mind." At this conference he will present his clinical findings that concussions sustained by both boys and girls during elementary school, too often unrecognized, develop into post-concussion syndrome problems during adolescence. And that this progressive neurodegenerative process can become crippling for an individual by the time they reach college age and beyond.

"Will be Updated Soon..."

Passionate about public health innovation, Gisèle Kaningini Furaha has been supporting research advancements at the INRB (National Institute of Biomedical Research) for over five years. As a Project Manager, she serves as a vital bridge between scientific rigor and operational field realities. Her presentation today focuses on the EBOSURV vaccine, a project at the heart of vaccine response strategies. Gisèle strives to demonstrate how rigorous project management can accelerate access to life-saving medical tools."

Prof. Andrey Dmitrovskiy was born in Almaty(1950), graduated from Medical Institute (1973), worked in infectious diseases hospitals, completed two–year residency at Kazakh Institute of Epidemiology (1979), worked at Anti-Plague Institute (1979 - 1999), from junior researcher till head of department. Defended PhD and doctoral dissertations, for diagnostics, treatment and epidemiology of zoonotic and extremely dangerous infections (Yersinioses and Plague). Since 2000, he was professor at Kazakh National Medical University, Infectious Diseases Department. In 2005 – 09, in parallel, worked in the Central Asian Office of CDC, USA and in 2011-16 in AECOM, USA as a manager for sustainable development. Since 2018, he is the head of Diagnostics and ExpertiseLaboratory of National Center for Biotechnology, Almatybranch (Central Reference Laboratory), in parallel - professor at Kazakh-Russian Medical University, ID Department. Under his leadership, 10 PhD and 3 doctoral dissertations were defended, he published over 425 printed works, including 6 monographs. He worked on outbreaks of a number of dangerous infections, including cholera, anthrax, plague, hemorrhagic fevers and COVID-19 in Kazakhstan, Uzbekistan, Tajikistan and Vietnam. Area of interest are diagnostics, treatment and epidemiology of infectious diseases, antiepidemic measures and biosafety.

Prof. Tingzhong Yang is a Professor and Director at the Research Center for Digital Health Theory and Management, ZJU National Health Big Data Institute. He has advised the WHO on tobacco control and contributed to the WHO Global Action Plan for NCDs prevention. Dr. Yang is also an external faculty member at West Virginia University’s Injury Control Research Center and was invited as an academician of the Russian Academy of Social and Fundamental Sciences. His research focuses on social and behavioral science in health. He has published over 130 international papers and several books, including Health Research: Social and Behavioral Theory and Methods. Dr. Yang developed China-specific models and a theoretical framework for digital health behavior. He is an editor for the Global Journal of Social Sciences Studies.

"Will be Updated Soon..."

Dr. Mohammadali Zolfaghari is a passionate and dedicated PhD professional in Molecular Medicine, with a strong foundation in medical laboratory sciences and specialized expertise in regenerative medicine, immunotherapy, and personalized medicine. He currently serves as the Research and Development Manager at the Molecular Immunology Research Center, Tehran University of Medical Sciences, where he leads multidisciplinary research teams focused on translating innovative laboratory discoveries into meaningful clinical applications. His work emphasizes the development of novel, patient-centered therapeutic strategies that address unmet medical needs. Dr. Zolfaghari’s research experience includes the design and execution of advanced experimental studies, with a particular focus on personalized medicine approaches and immunotherapeutic interventions. His scientific contributions aim to advance treatment paradigms across a range of diseases by integrating molecular insights with clinical relevance. With a strong commitment to ethical research practices and regulatory compliance, Dr. Zolfaghari combines scientific rigor with practical expertise to navigate complex biomedical challenges and contribute to the future of precision medicine.

Dr. Amrita Natarajan is a biomedical researcher with a multidisciplinary background in dentistry, nanomedical sciences, and bioengineering. She holds a B.D.S. from the Army College of Dental Sciences, an M.Tech in Nanomedical Sciences from AIMS, and a Ph.D. in Bioengineering with a focus on Tissue Engineering and Regenerative Medicine from SCTIMST, India. She has received prestigious fellowships from ICMR and CSIR, and has worked on DST-SERB-funded research. Her expertise lies in the development of advanced biomaterials, 3D bioprinted constructs, and in vitro disease models for regenerative therapies targeting cartilage, bone, and kidney tissues. Her work includes biomimetic scaffolds for cartilage repair, patterned hydrogels for renal tissue modeling, electrospun tubule models, and 3D-printed lattice scaffolds for various tissue regeneration applications. Dr. Natarajan previously served as Project Scientist C at ICMR, where she contributed to national biomedical ethics policy, including India’s 2023 CHIS policy statement. Currently, she is a National Science Foundation–funded Postdoctoral Research Scientist at Alabama State University, focusing on AI-driven renal tissue engineering. She also serves on doctoral advisory committees at multiple institutions. Her long-term vision integrates bioinspired design with advanced fabrication technologies for tissue repair and organ function restoration.

Dr. Rafei is an immunologist by training focused on the development of therapies within the immuno-oncology space. Throughout the past decade, he accumulated profound knowledge and insight in the fields of T-cell development, stem cell biology, cancer immunotherapy and autoimmune diseases. So far, he is considered as a leader in the development of immune-related therapies for catastrophic illnesses with many uncovered seminal discoveries, some of which are currently being tested in clinical trials. So far, Dr Rafei received over 24 awards and recognitions and his research has resulted in over 60 high impact peer-reviewed publications, 5 reviews, 2 book chapters, 1 monograph, and 7 patents.

Prof. Bernd Blobel studied Mathematics, Technical Cybernetics and Electronics, Bio-Cybernetics, Physics, Medicine and Informatics at the University of Magdeburg and other universities in the former GDR. He received his PhD in Physics with a neurophysiological study. Furthermore, he performed the Habilitation (qualification as university professor) in Medicine and Informatics. He was Head of the Institute for Biometrics and Medical Informatics at the University of Magdeburg, and thereafter Head of the Health Telematics Project Group at the Fraunhofer IIS in Erlangen. Thereafter, he acted until his retirement as Head of the German National eHealth Competence Center at the University of Regensburg as well as Head of the globally unique International Interdisciplinary PhD and PostDoc College. He was and is still leadingly involved in many countries health digitalization as well as electronic health record strategy. He published more than 600 papers, published/edited many books and supervised a big number of PhD students from all around the world. He was German Representative to many SDOs such as HL7, ISO, CEN, OMG, IEEE, ASTM, SNOMED, etc., also chairing the national mirror groups. Furthermore, he still engaged in international higher education.He is Fellow of several international academies.

"Will be Updated Soon..."

Dr. Wenxiao Liu specializes in the pathogenesis and control strategies of infectious diseases in dairy cattle. Her research integrates molecular biology and digital technologies to develop rapid diagnostic reagents for common bovine infectious diseases. Dr. Wenxiao Liu is actively involved in the development of novel vaccines against herpesviruses and Brucella, and conducts in-depth studies on the antimicrobial resistance mechanisms of Pasteurella multocida. This includes uncovering the molecular basis of cross-species transmission of antimicrobial-resistant pathogens and resistance genes from livestock and poultry.

Dr. Rajeeb K Sah is a Reader (Associate Professor) in Public Health and the International Lead for the Department of Allied Health Professions, Sports, and Exercise at the University of Huddersfield, UK. A Fellow of the Higher Education Academy (FHEA) and the Royal Society of Public Health (FRSPH), he holds an MSc and PhD in Public Health and is also a qualified Medical Doctor. His interdisciplinary research focuses on global health, social determinants of health, sexual and reproductive health, mental health, and health inequalities. A qualitative researcher, he employs co-production, ethnography, and participatory approaches in his work. Dr. Sah currently leads and collaborates on multiple community health projects in West Yorkshire and supervises PhD students in related fields.

Dr. Kadhim AlAbady is a distinguished public health and epidemiology expert with over 20 years of experience across academic, international, and national health systems. He is a Fellow of the Faculty of Public Health (FFPH), UK, and a Fellow of the Royal College of Physicians and Surgeons of Glasgow (FRCP). He holds a Doctorate in Public Health and Epidemiology, along with an MSc in Clinical Epidemiology and an MPH, all from universities in the Netherlands, and is a Grade A registered Epidemiologist with the Netherlands Epidemiological Society. Dr. AlAbady has held senior roles at leading institutions including Erasmus University, Queen Mary University of London, University of East Anglia, the United Nations, the UK NHS, Qatar’s National Health Authority, and the Dubai Health Authority.

Asifa Khanum is a senior public health and development professional with over 30 years of experience in monitoring, evaluation, research, grant management, and program planning across Pakistan. She serves as Director of Monitoring, Evaluation, and Research (MER) at the Rahnuma-FPAP, where she leads M&E systems, data innovations, and evidence-generation efforts. She has extensive experience designing log frames, theories of change, performance monitoring frameworks, digital data systems, and mixed-methods research for large-scale SRHR, youth, and humanitarian programs. She also serves as Acting Director of Program Planning, strengthening institutional proposal development, donor engagement, compliance, and strategic planning processes. Her research and evaluation portfolio includes assignments for CARE International, UNFPA, ILO, JICA, Population Council, WHO, and Contech International. She has represented Rahnuma-FPAP in national technical groups and advisory teams. Asifa has presented widely at regional and global forums including: International Conference on Family Planning, Colombia (2025) and Ethiopia (2013), Annual Public Health Conference, Pakistan (2022), Asia Pacific Conference on Reproductive and Sexual Health and Rights, Vietnam (2017) and Philippines (2024), in addition to representing the organization at national and international meetings, seminars, and workshops. Asifa is one of the lead researchers for a national study titled ‘Situation Analysis of Breast and Cervical Cancer in Pakistan’, conducted in 2023–24, funded by the WHO Pakistan. This landmark study provided critical evidence on the burden of cervical cancer and articulated the nexus between HPV vaccination, supporting national efforts toward cervical cancer elimination. With Masters degrees in Statistics, and Gender Studies, she remains committed to evidence-driven, rights-based, and locally led approaches to public health.

Dr. Amrita is a highly accomplished scientist with a PhD in Molecular Medicine and a Master’s degree in Immunology, specializing in regenerative medicine, immunotherapy, and cellular therapies, with particular expertise in CAR-based cell therapies. She holds diplomas from the American Board of Regenerative Medicine (ABRM) and is a member of the American Society of Regenerative Medicine. Her research excellence has been recognized with multiple honors, including the Extraordinary Young Scientist Award (2024) from the American Society of Regenerative Medicine and the Brilliant Talent of National Medical Sciences Student Award. She has successfully translated research into practice, securing a National Science and Technology Parks grant for a CAR-NK cellular cancer therapy project. Dr. Amrita has extensive experience teaching immunology and regenerative medicine to medical doctors and PhD candidates and is frequently invited as a keynote speaker at international conferences.

Ms. Hawa Abdillah is a dedicated PhD candidate in Psychology at Central South University, Xiangya School of Nursing, China. Originally from Comoros, her doctoral research focuses on the critical issue of child sexual abuse, with an emphasis on understanding its psychological impacts and developing effective prevention strategies within the Comorian context. Her work bridges cultural perspectives and psychological theories, offering valuable insights into child protection and mental health. In addition to her academic research, Hawa is actively involved in community outreach initiatives, raising awareness about child sexual abuse, advocating for the protection of vulnerable populations, and promoting mental health support and well-being for survivors.

Dr. Gianluca Straface is an accomplished obstetrician and gynecologist currently serving as the Head of the Obstetrics Unit at Policlinico Abano Terme, Italy. With over two decades of clinical, academic, and research experience, he has made significant contributions to maternal-fetal medicine, perinatal diagnostics, and fetal therapy. He earned his Medical Degree from the University of Rome “La Sapienza” and later completed his Specialization in Obstetrics and Gynecology at the Catholic University of the Sacred Heart, Rome, graduating with honors. Dr. Straface has previously worked at several renowned Italian hospitals, including Ospedale Santo Spirito in Rome, and served as a lecturer at the Interactive Patient Simulation Experience (IPSE) Center of Policlinico A. Gemelli. His research focuses on fetal development, teratology, obstetric pathologies, and perinatal outcomes, with numerous international publications in high-impact journals. He has also contributed to the training of medical professionals through advanced obstetrics and gynecology courses and continues to be an active member of interdisciplinary fetal research groups in Italy.

Mr. Alibek Adil is a PhD student and infectious disease specialist at the Kazakh-Russian Medical University in Almaty, Kazakhstan. His research focuses on vector-borne and zoonotic infections, particularly Lyme disease and other tick-borne diseases, with an emphasis on their clinical and epidemiological manifestations. He has been engaged in serological and molecular studies in natural foci of infections, contributing to improved diagnostic and preventive strategies in Kazakhstan. In addition to research, Alibek Adil lectures on infectious diseases and develops modern educational resources for medical students, with the aim of integrating clinical practice and public health perspectives. His broader academic interests include emerging zoonoses, viral hepatitis, and public health approaches to the prevention of infectious diseases.

Dr. Joseph Mwaka is a medical doctor and clinical research professional with extensive experience managing and coordinating health research projects across Africa. He holds an MSc in International Health and Tropical Medicine from the University of Oxford, an MSc in Vaccinology from the University of Siena, and an MPH from Cavendish University Uganda. At Mildmay Research Centre Uganda, he leads multi-institutional research initiatives focused on vaccines, clinical trials, and digital health innovation. His work bridges implementation science, ethics oversight, and public health policy to strengthen immunization systems in low-resource settings. Dr. Mwaka has presented at global scientific forums and co-authored peer-reviewed publications on vaccination strategies, AI in health, and ethical research governance.

"Will be Updated Soon..."

Schola Kamwethya Peter is a Kenyan Biomedical Researcher specializing in infectious diseases and antimicrobial resistance, with a focus on vaccine introduction and evaluation, immunity, diagnostics, and disease prevention strategies. She is currently pursuing a PhD in Immunology at the University of Nairobi, building on her MSc in Immunology from Kenyatta University and BEd in Science from Pwani University. Schola works at the Kenya Medical Research Institute (KEMRI) as a Research Assistant, contributing to high-impact studies on oral cholera vaccine evaluation, Salmonella Typhi and Non-Typhoidal Salmonella, and gastrointestinal infections to inform vaccine policy and introduction. Passionate about improving health outcomes in sub-Saharan Africa, she is committed to advancing research that reduces the burden of infectious diseases.

"WIll be Updated Soon..."

"Will be Updated Soon..."